Renalytix (RNLX) to Release Quarterly Earnings on Wednesday

Renalytix (NASDAQ:RNLX) will be posting its quarterly earnings results before the market opens on Wednesday, May 15th.

Renalytix (NASDAQ:RNLX) last issued its quarterly earnings results on Wednesday, February 14th. The company reported ($0.09) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.09). The firm had revenue of $0.71 million during the quarter, compared to the consensus estimate of $0.70 million. Renalytix had a negative return on equity of 1,008.88% and a negative net margin of 1,736.47%.

Renalytix Price Performance

RNLX stock opened at $0.63 on Friday. Renalytix has a 1 year low of $0.24 and a 1 year high of $4.04. The company’s 50-day moving average is $0.87 and its 200-day moving average is $0.68. The stock has a market capitalization of $48.89 million, a PE ratio of -1.41 and a beta of 3.05.

About Renalytix

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.